Upon completion of this course, participants should be able to:

1. Have a better understanding of pre-cancer treatment dental care
2. Know the oral protocols for patients with cancer
3. Understand how to reduce caries in patients with cancer

One of the authors (JP) is a six-year cancer survivor of squamous cell carcinoma; many of these clinical suggestions are based on his experiences. In joint effort with Loyola university, Cardinal Bernadin Cancer Center, a restrospective study makes up the remainder of the recommended approaches and products and their effective uses.





ADA CERP Disclosure: The author of this Continuing Education Activity receives ongoing financial consideration from DrBicuspid.com for preparation of these CE course materials.   Author has disclosed that they do not have any real or perceived conflict of interest in preparing this educational activity, nor does this activity discuss any unlabeled or unapproved drug or device.

1. Introduction
2. Phase I: Pre-cancer Treatment Dental Examination
3. Pre-cancer treatment dental appointment No.1
4. Pre-cancer treatment dental appointment No. 2
5. Phase II: Dental treatment during cancer therapy
6. Chemotherapy-induced complications
7. Management of Mucositis
8. Management of Mucositis Continued
9. Mucositis-Associated Infection
10. Viral Infection
11. Mucositis
12. Dysgeusia
13. Xerostomia
14. Prevention of Xerostomia
15. Candidiasis
16. Depression
17. Dental care after surgery for head and neck cancer
18. Phase III: Dental care following active cancer therapy

1. King GE, Toth BB, Fleming TJ. Oral dental care of the cancer patient. Tex Dent J 1988;105:10-11,68
2. Barker GJ, barker BF, Gier RE. Oral management of the cancer patient: A guide for the health care professional, ed. 5. Kansas City, MO: University of Missouri-Kansas City School of Dentistry; 1996.
3. National Institutes of Health consensus development conference statement: Oral complications of cancer therapies: Diagnosis, prevention, and treatment. J Am Dent Assoc 1989;119:179-183.
4. Silverman S Jr. Current concepts in the management of oral/dental adverse sequelae of head and neck radiotherapy. In: Meyer JL, ed. Radiation injury: Advances in management and prevention. Basel, Switzerland: karger; 1999:43-48.
5. Toth BB, Chambers MS, Fleming TJ, Lemon JC, Martin JW. Minimizing oral complications of cancer treatment. Oncology (Williston Park) 1995;9:851-858.
6. Scales used for assessing oral mucositis. Available at: http://symptomresearch.nih.gov/Chapter_17/sec7/cghs7table71pop1.htm. Accessed March 9, 2007
7. World Health Organization. Handbook for reporting results of cancer treatment. Geneva, Switzerland: World Health Organization; 1979:15-22.
8. Million RR, cassisi NJ. Management of head and neck cancer: A multidisciplinary approach, ed. 2. Philadelphia: Lippincott; 1994.
9. RankinKV, Jones DL, Redding SW eds. Oral health in cancer therapy: A guide for health care professionals, ed. 2. Available at” http://www.doep.org/OHCT2monographrevised.pdf Accessed April 20,2007
10. Ramirez-Amador V, Silverman S Jr, mayer P, Tyler M, Quivey J. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Oral med Oral Pathol Oral Radiol Endod 1997;84:149-153.
11. Thambi V, Murthy AK, Alder G, Kartha PK. Dose perturbation resulting from gold fillings in patients with head and neck cancers. Int J Radiat Oncol Bio Phys 1979;5:581-582
12. Rosengren B, Wulff L, Carlsson E, Carlsson J, Montelius A, Russell K, Grusell E. backscatter at tissue-titanium interfaces. Analysis of biologic effects from 60Co and protons. Acta Oncology 1995;34:859-866
13. Melian E, Fatyga M, Lam P, Steinberg M, Reddy SP, Petruzzelli GJ, Glasgow GP. Effect of metal reconstruction plates on cobalt-60 dose distribution: A predictive formula and clinical implications. Int J Radiat Oncol Biol Phys 1999;44:725-730
14. Li XA, Chu JC, Chen W, Zusag T. Dose enhancement by a thin foil of high-Z material: A Monte Carlo study. Med Phys 1999;26:1245-1251
15. Nadrowitz R, Feyerabend T. Backscatter dose from metallic materials due to obliquely incident high-energy photon beams. Med Phys 2001;28:959-965
16. Fleming TJ, Rambach SC. A tongue-shielding radiation stent. J Prosthet Dent 1983;49:389-392
17. Das U, kahm FM. Backscatter dose perturbation at high atomic number interfaces in megavoltage photon beams. Medical Physics 1989;16:367-375.
18. Scrimger JW. Backscatter from high atomic number materials in high energy photon beams. Radiology 1977;124:815-817
19. Gibbs FA, Palos B, Goffinet DR. The metal/tissue interface effect in irradiation of the oral cavity. Radiology 1976;119:705-707
20. Tatcher M, Kuten A, Helman J, Laufer D. Perturbation of cobalt 60 radiation doses by metal objects implanted during oral and axillofacial surgery. J Oral maxillofac Surg 1984;42:108-110
21. Sauer O. Calculation of does distributions in the vicinity of high-Z interfaces for photon beams. Med Phys 1995;22:1685-1690
22. Reitemeier B, Reitemeier G, Schmidt A, Schaal W, Blochberger P, Lehmann D, Hermann T. Evaluation of a device for attenuation of electron release from dental restorations ina therapeutic radiation field. J Prosthet Dent 2002;87:323-327
23. Fuller CD, Diaz I, Cavanaugh SX, Eng TY. In vivo dose perturbation effects of metallic dental alloys during head and neck irradiation with intensity modulated radiation therapy. Oral Oncol 2004;40:645-648
24. Thilmann C, Adamietz IA, Rahn R, Mose S, Saran F, Schopohl B, Bottcher HD. [The In-vivo determination of dosage intensification due to dental alloys in the therapeutic irradiation of the oral cavity] [article in German]. Strahlenther Onkol 1995;171:468-472
25. Thilmann C, Adamietz IA, Ramm U, Rahn R, Mose S, Saran F, Bottcher HD. In-vivo dose increase in the presence of dental alloys during 60Co Gamma-ray therapy of the oral cavity. Med Dosim 1996;21:149-154
26. Farahani M, Eichmiller FC, McLaughlin WL. Measurement of absorbed doses near metal and dental material interfaces irradiated by x and gamma-ray therapy beams. Phys Ned Biol 1990;35:369-385
27. Schratter-Sehn AU, Schmidt WF, Keilhauser R, Langer H, karcher KH. [The prevention of mucosal lesions during oropharyngeal irradiation with a dental-fillinf shield] [article in German]. Stranlenther Onkol 1992;168:35-38
28. Wang R, Boyle A. A convenient method for guarding against localized mucositis during radiation therapy. J Prosthodont 1994;3:198-201
29. Wang RR, Pillai K, Jones PK. In vitro backscattering from implant material during radiotherapy. J Prosthet Dent 1996;75:626-632
30. Ravikumar M, Ravichandran R, Supe SS. Forward scatter dose effect at metallic interfaces irradiated by X and gamma ray therapy beams. Stranhlenther Onkol 2004;180:173-178
31. Nilsson B, Montelius A, Andreo P. A study of interface effects in 60Co beams using a thin-walled parallel plate ionization chamber. Med Phys 1992;19:1413-1421
32. Eating hints for cancer patients: Before, during and after treatment. Bethesda, MD: National Institute of Health; 1998
    Haveman CW. Xerostomia management in the head and neck radiation patient. Texas Dent J 2004;6:121
33. What is trismus? Available at: http://www.oralcancerfoundation.org/dental/trismus.htm. Accessed on April 20, 2007
34. Buchblinder D, Currivan RB, Kaplan AJ, Urken ML. Mobilization regimens for the prevention of jaw hypomobility in the radiated patient: A comparison of three techniques. J Oral Maxillofac Surg 1993;51:863-867
35. Available at: http://www.healthline.com/galecontent/prophylactic-antibiotic-premedication. Accessed May 2008
36. Drug Information. Available at: http://www.mayoclinic.com/health/drug-information/DrugHerbIndex. Accessed may 2008